Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2011 | 1 |
2015 | 1 |
2018 | 1 |
2019 | 1 |
2020 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Imeglimin population pharmacokinetics and dose adjustment predictions for renal impairment in Japanese and Western patients with type 2 diabetes.
Clin Transl Sci. 2022 Apr;15(4):1014-1026. doi: 10.1111/cts.13221. Epub 2022 Jan 17.
Clin Transl Sci. 2022.
PMID: 34962074
Free PMC article.
A Physiologically-Based Pharmacokinetic (PBPK) Model Network for the Prediction of CYP1A2 and CYP2C19 Drug-Drug-Gene Interactions with Fluvoxamine, Omeprazole, S-mephenytoin, Moclobemide, Tizanidine, Mexiletine, Ethinylestradiol, and Caffeine.
Kanacher T, Lindauer A, Mezzalana E, Michon I, Veau C, Mantilla JDG, Nock V, Fleury A.
Kanacher T, et al. Among authors: mezzalana e.
Pharmaceutics. 2020 Dec 8;12(12):1191. doi: 10.3390/pharmaceutics12121191.
Pharmaceutics. 2020.
PMID: 33302490
Free PMC article.
Item in Clipboard
Target engagement and cellular fate of otelixizumab: a repeat dose escalation study of an anti-CD3ε mAb in new-onset type 1 diabetes mellitus patients.
Vlasakakis G, Napolitano A, Barnard R, Brown K, Bullman J, Inman D, Keymeulen B, Lanham D, Leirens Q, MacDonald A, Mezzalana E, Page K, Patel M, Savage CO, Zamuner S, van Maurik A.
Vlasakakis G, et al. Among authors: mezzalana e.
Br J Clin Pharmacol. 2019 Apr;85(4):704-714. doi: 10.1111/bcp.13842. Epub 2019 Feb 5.
Br J Clin Pharmacol. 2019.
PMID: 30566758
Free PMC article.
Clinical Trial.
Item in Clipboard
MPBPK-TMDD models for mAbs: alternative models, comparison, and identifiability issues.
Lavezzi SM, Mezzalana E, Zamuner S, De Nicolao G, Ma P, Simeoni M.
Lavezzi SM, et al. Among authors: mezzalana e.
J Pharmacokinet Pharmacodyn. 2018 Dec;45(6):787-802. doi: 10.1007/s10928-018-9608-7. Epub 2018 Nov 10.
J Pharmacokinet Pharmacodyn. 2018.
PMID: 30415351
Item in Clipboard
Temporal pharmacokinetic/pharmacodynamic interaction between human CD3ε antigen-targeted monoclonal antibody otelixizumab and CD3ε binding and expression in human peripheral blood mononuclear cell static culture.
Page KR, Mezzalana E, MacDonald AJ, Zamuner S, De Nicolao G, van Maurik A.
Page KR, et al. Among authors: mezzalana e.
J Pharmacol Exp Ther. 2015 Nov;355(2):199-205. doi: 10.1124/jpet.115.224899. Epub 2015 Sep 4.
J Pharmacol Exp Ther. 2015.
PMID: 26341624
Item in Clipboard
Multinomial logistic functions in markov chain models of sleep architecture: internal and external validation and covariate analysis.
Bizzotto R, Zamuner S, Mezzalana E, De Nicolao G, Gomeni R, Hooker AC, Karlsson MO.
Bizzotto R, et al. Among authors: mezzalana e.
AAPS J. 2011 Sep;13(3):445-63. doi: 10.1208/s12248-011-9287-4. Epub 2011 Jun 21.
AAPS J. 2011.
PMID: 21691915
Free PMC article.
Item in Clipboard
Cite
Cite